brolucizumab

E1997503 UNEXPLORED

Brolucizumab is an anti-VEGF monoclonal antibody used as an intravitreal injection to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
brolucizumab canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Vascular endothelial growth factor A targetOfDrug brolucizumab